Table 3 Uncertainty arising from diagnostic, variant of uncertain significance, and no-finding results from whole genome sequencing described in patient letters.

From: Written communication of whole genome sequencing results in the NHS Genomic Medicine Service: a multi-centre service evaluation

Result type

Dimension of uncertainty

Description

Number of letters

Illustrative quote(s) from letter

Diagnostic

Issue

Prognostic uncertainty (inability to supply a clear and accurate prognosis from the diagnosis)

12/13

“it could not be predicted how mildly or severely children might be affected”

Source

Limited knowledge and data about the condition

7/13

“there is little data available about the outcomes in adults or life expectancy”

Management

Emphasising diagnostic uncertainty

10/13

“The change in the gene causes it to malfunction with certainty and therefore, this is a secure diagnosis”

Hope for future certainty

5/13

“…with emerging literature, I suspect that most of these previously described conditions are also likely to have a milder presentation which will become obvious in due course”

Diagnostic

Issue

Diagnostic uncertainty (inability to determine whether a specific feature could be attributed to the diagnosed condition)

3/13

“there are no known heart problems previously reported with this condition”

Source

Limited knowledge about the condition or an alternative cause

2/13

“it is possible that his potential bicuspid aortic valve may be an extra detail that is not known about the condition” “Syndactyly of the 4th and 5th fingers is not reported in X disorder and may have a separate genetic or non-genetic basis or may be a very rare feature”

VUS

Issue

Diagnostic uncertainty (an inability to determine if the variant is causing the patient’s phenotype)

10/10

“This may simply be a healthy variant (of which we all have thousands) and not the cause… However, there is a small chance that it is the cause”

Source

Insufficient evidence for accurate variant interpretation

10/10

“at present, there is not enough scientific evidence to confirm whether the change in the gene is harmful and, therefore, causative of X’s problems”

Management

Hope for future certainty

9/10

“knowledge about genes and their variations constantly increases, and as new information becomes available we will hopefully be able to arrive at conclusive genetic diagnosis”

Providing a clinical judgement about the likelihood of VUS causality

4/10

“this is likely to be harmless background change” “…identification of a further individual with the same gene change would be sufficient for it to be upgraded to pathogenic”

No-finding

Issue

Diagnostic uncertainty (an inability to confirm that the phenotype is not genetic in cause)

11/14

“…does not completely exclude the possibility of an underlying genetic condition” “this does not rule out a genetic problem”

Source

Imperfect testing

7/14

“it is possible that he has a genetic condition that we are unable to detect with current technologies”

Limited knowledge about genetic changes that cause disease

7/14

“it is still possible… caused by a change in a gene or genetic region not yet known to be associated with X”

Possible multifactorial cause

3/14

“we need to consider that X’s difficulties do not have a single gene background. In other words, X’s difficulties may be multifactorial”

Possible non-genetic cause

3/14

“it may be that X does not have a clear strong genetic factor causing his problems”

Insufficient clinical data

1/14

“To help us investigate things further we would like to undertake a skeletal survey to see if there are any further clues”

Management

Hope for future certainty

8/14

“as genetic technology improves, it is possible that future genetic testing could reveal a cause”